Argitalpenak (58) SALVADOR MATEO ÁLVAREZ argitalpenak

2018

  1. Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016

    Influenza and other Respiratory Viruses, Vol. 12, Núm. 1, pp. 161-170

2017

  1. Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain

    PLoS ONE, Vol. 12, Núm. 6

  2. Pilot study to harmonize the reported influenza intensity levels within the Spanish Influenza Sentinel Surveillance System (SISSS) using the Moving Epidemic Method (MEM)

    Epidemiology and Infection, Vol. 145, Núm. 4, pp. 715-722

2016

  1. Vigilancia del virus respiratorio sincitial en el marco del Sistema de Vigilancia de la Gripe en España, 2006-2014

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 2, pp. 117-120

  2. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15

    Vaccine, Vol. 34, Núm. 20, pp. 2371-2377

2015

  1. Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data

    Eurosurveillance, Vol. 20, Núm. 28

  2. Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014

    Vaccine, Vol. 33, Núm. 29, pp. 3276-3280

2014

  1. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: Test-negative case-control studies using surveillance data, Spain, 2003-2011

    Vaccine, Vol. 32, Núm. 35, pp. 4404-4411

  2. Hipofosfatemia, una reacción adversa poco conocida del hierro intravenoso

    Medicina Clinica

  3. Influenza vaccine effectiveness in Spain 2013/14: Subtype-specific early estimates using the cycEVA study

    Eurosurveillance, Vol. 19, Núm. 9

  4. Síndrome de platipnea-ortodeoxia

    Revista Clinica Espanola, Vol. 214, Núm. 6

2013

  1. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination

    BMC Infectious Diseases, Vol. 13, Núm. 1

  2. Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study

    PLoS Medicine, Vol. 10, Núm. 11

2012

  1. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: Results from the I-MOVE multicentre case-control study, 2011/12

    Eurosurveillance, Vol. 17, Núm. 15, pp. 1-7

  2. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012

    Eurosurveillance, Vol. 17, Núm. 12

  3. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: CycEVA study

    Vaccine, Vol. 30, Núm. 24, pp. 3595-3602

  4. Harm reduction interventions for drug injectors or heroin users in Spain: Expanding coverage as the storm abates

    Addiction, Vol. 107, Núm. 6, pp. 1111-1122

  5. Influenza-related mortality in Spain, 1999-2005

    Gaceta Sanitaria, Vol. 26, Núm. 4, pp. 325-329

2011

  1. Actividad de la gripe pandémica (H1N1) 2009 durante el verano de 2009. Efectividad de la vacuna trivalente 2008-9 frente a la gripe pandémica en España

    Gaceta Sanitaria, Vol. 25, Núm. 1, pp. 23-28

  2. Differences in the reproductive pattern and low birthweight by maternal country of origin in Spain, 1996-2006

    European Journal of Public Health, Vol. 21, Núm. 1, pp. 104-108